Acute myelogenous leukemia: Advances and limitations of treatment
- 1 March 2002
- journal article
- case report
- Published by Elsevier in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 93 (3) , 257-263
- https://doi.org/10.1067/moe.2002.121988
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor–induced proliferation and maturationExperimental Hematology, 2000
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?British Journal of Haematology, 2000
- Analysis of oral manifestations of leukemia: a retrospective studyOral Diseases, 1997
- Prognostic factors in myelodysplastic syndromes: Analysis of five scoring systemsHematological Oncology, 1995
- SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIALTransplantation, 1994
- THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIATransplantation, 1992
- Calicheamicin γ 1 I : an Antitumor Antibiotic That Cleaves Double-Stranded DNA Site SpecificallyScience, 1988